Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Acta Crystallographica. Section D, Biological Crystallography
|
April 17, 2012
Handling ligands with Coot
Judit É Debreczeni, Paul Emsley
Acta Crystallographica. Section D, Structural Biology
|
February 9, 2017
Ligand complex structures in protein crystallography
Judit É Debreczeni, Paul Emsley
SLAS Discovery : Advancing Life Sciences R & D
|
October 5, 2020
Cryo-EM: The Resolution Revolution and Drug Discovery
Taiana Maia de Oliveira, Lotte van Beek, Fiona Shilliday, et al.
Journal of Medicinal Chemistry
|
September 26, 2014
Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors
John G Cumming, Judit É Debreczeni, Fredrik Edfeldt, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M Mutation
Edward J Hennessy, Claudio Chuaqui, Susan Ashton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 5, 2023
Cryo-EM structure determination of small therapeutic protein targets at 3 Å-resolution using a rigid imaging scaffold
Roger Castells-Graells, Kyle Meador, Mark A Arbing, et al.
Journal of Medicinal Chemistry
|
May 22, 2026
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluation
James M Smith, Bernard Barlaam, David Beattie, et al.
Journal of Medicinal Chemistry
|
August 13, 2013
Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)
Richard A Ward, Mark J Anderton, Susan Ashton, et al.
Journal of Medicinal Chemistry
|
July 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
James M Smith, Bernard Barlaam, David Beattie, et al.
Acta Crystallographica. Section D, Structural Biology
|
June 1, 2023
The CCP4 suite: integrative software for macromolecular crystallography
Jon Agirre, Mihaela Atanasova, Haroldas Bagdonas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Acta Crystallographica. Section D, Biological Crystallography
|
April 17, 2012
Handling ligands with Coot
Judit É Debreczeni, Paul Emsley
Acta Crystallographica. Section D, Structural Biology
|
February 9, 2017
Ligand complex structures in protein crystallography
Judit É Debreczeni, Paul Emsley
SLAS Discovery : Advancing Life Sciences R & D
|
October 5, 2020
Cryo-EM: The Resolution Revolution and Drug Discovery
Taiana Maia de Oliveira, Lotte van Beek, Fiona Shilliday, et al.
Journal of Medicinal Chemistry
|
September 26, 2014
Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors
John G Cumming, Judit É Debreczeni, Fredrik Edfeldt, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M Mutation
Edward J Hennessy, Claudio Chuaqui, Susan Ashton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 5, 2023
Cryo-EM structure determination of small therapeutic protein targets at 3 Å-resolution using a rigid imaging scaffold
Roger Castells-Graells, Kyle Meador, Mark A Arbing, et al.
Journal of Medicinal Chemistry
|
May 22, 2026
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluation
James M Smith, Bernard Barlaam, David Beattie, et al.
Journal of Medicinal Chemistry
|
August 13, 2013
Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)
Richard A Ward, Mark J Anderton, Susan Ashton, et al.
Journal of Medicinal Chemistry
|
July 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
James M Smith, Bernard Barlaam, David Beattie, et al.
Acta Crystallographica. Section D, Structural Biology
|
June 1, 2023
The CCP4 suite: integrative software for macromolecular crystallography
Jon Agirre, Mihaela Atanasova, Haroldas Bagdonas, et al.
Page
of 1